세계의 비만 치료 시장 점유율, 규모, 동향, 산업 분석 리포트 : 수술 유형별, 약제 유형별, 최종사용자별, 지역별, 부문 예측(2022-2030년)

The global Obesity Treatment market size is expected to reach USD 32.51 billion by 2030, according to a new study by Polaris Market Research. The report "Obesity Treatment Market Share, Size, Trends, Industry Analysis Report, By Surgery Type (Biliopancreatic diversion with Duodenal Switch (BPD/DS), Adjusting gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy, and Endoscopic Procedures); By Drug Type; By End-Use; By Region; Segment Forecast, 2022-2030" gives a detailed insight into current market dynamics and provides analysis on future market growth.

More and more people are changing their lifestyles to include lousy eating, drinking, and sleeping less, which led to obesity being a major factor boosting the market over the forecast period. Overweight rates have risen recently due to work-from-home practices, a lack of exercise, and bad routines. Unhealthy eating habits and trends, such as ordering food online and buying more packaged and ready-to-eat foods, have significantly impacted a large portion of the population. Dieting is a lifestyle adjustment, and physical activity has a notable impact on body weight management. Professionals advise hypocaloric diets and continuous power restrictions to achieve weight loss targets. Fatness is strongly correlated with smoking and reduced consumption of sugary or carbonated beverages.

The expansion of the obesity treatment sector is significantly impacted by the rising awareness of the illness, even in developing nations. Growing weight control programs, applications, and websites that direct and track a person's regular activity have raised public awareness of the dangers of being overweight. Rising wearables and electronic gadgets that continuously track health metrics have had a significant impact on the development of the industry in recent years.

One of the main drivers of market expansion is the rise in government activities to address the problem of overweight people and the increased development of cutting-edge and efficient weight control procedures. For instance, the UK Government announced new regulations to combat obesity and a "Better Health" campaign in July 2020 to motivate people to lose weight and enhance their general health. Although encouraging individuals to better their health is a good goal, this has positively impacted the market growth.

The development of this treatment operation and the technologies used in those surgeries have supported the industry's expansion in recent years. The market is anticipated to expand steadily throughout the forecast period owing to efforts and medical associations' favorable recommendations. The market is thought to be primarily driven by the decline in cardiovascular risk and the consequences of diabetes following bariatric surgery.

Obesity Treatment Market Report Highlights

Biliopancreatic Diversion with Duodenal Switch (BPD/DS) segment is anticipated to grow at the highest CAGR over the forecast period. In the upcoming years, this market's growth is expected to be supported by rising surgical procedures demand and the rising prevalence of overweight-related health concerns like hypertension, type 2 diabetes, and other medical disorders.

Combination therapies segment accounted high of the global revenue share. The prevalence of obesity is rising globally, and effective combination medicines for weight management are now available, which is driving this market's expansion.

Asia-Pacific is expected to grow significantly over the projected period. Raising public awareness of the harmful impacts of obesity, bettering healthcare facilities, and increasing medical tourism are significant drivers of growth in this region.

The global market includes AbbVie Incorporation, Boehringer, Herbalife Limited, Johnson & Johnson Services, Inc., NutriSystem, Incorporation, Olympus Corporation, Pfizer Incorporation, Technogym SpA, USGI Medical, Inc., and Vivus, Inc.

Polaris Market Research has segmented the Obesity Treatment market report based on surgery type, drug type, end-use, and region:

Obesity Treatment, Surgery Type Outlook (Revenue - USD Billion, 2018 - 2030)

Biliopancreatic diversion with Duodenal Switch (BPD/DS)

Adjusting Gastric Banding

Roux-en-Y Gastric Bypass

Sleeve gastrectomy

Endoscopic Procedures

Obesity Treatment, Drug Type Outlook (Revenue - USD Billion, 2018 - 2030)

Appetite suppressants

Combination drugs

Malabsorption

Satiety drugs

Obesity Treatment, End-Use Outlook (Revenue - USD Billion, 2018 - 2030)

Clinics

Hospitals

Beauty institutions

Others

Obesity Treatment, Regional Outlook (Revenue - USD Billion, 2018 - 2030)

North America

U.S

Canada

Europe

Germany

UK

France

Italy

Spain

Russia

Netherlands

Asia Pacific

China

India

Japan

South Korea

Indonesia

Malaysia

Latin America

Argentina

Brazil

Mexico

Middle East & Africa

UAE

Saudi Arabia

Israel

South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Obesity Treatment Market Insights

• 4.1. Obesity Treatment - Industry Snapshot
• 4.2. Obesity Treatment Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increasing prevalence of obesity among populations to propel product demand
    • 4.2.1.2. Robust drug pipeline to aid growth worldwide
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. Low treatment rate against the disorder to restrict market growth
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Obesity Treatment Market Industry Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Obesity Treatment Market, by Surgery Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
• 5.3. Biliopancreatic diversion with Duodenal Switch (BPD/DS)
  • 5.3.1. Global Obesity Treatment Market, by Biliopancreatic diversion with Duodenal Switch (BPD/DS), by Region, 2018 - 2030 (USD Billion)
• 5.4. Adjusting Gastric Banding
  • 5.4.1. Global Obesity Treatment Market, by Adjusting Gastric Banding, by Region, 2018 - 2030 (USD Billion)
• 5.5. Roux-en-Y Gastric Bypass
  • 5.5.1. Global Obesity Treatment Market, by Roux-en-Y Gastric Bypass, by Region, 2018 - 2030 (USD Billion)
• 5.6. Sleeve gastrectomy
  • 5.6.1. Global Obesity Treatment Market, by Sleeve gastrectomy, by Region, 2018 - 2030 (USD Billion)
• 5.7. Endoscopic Procedures
  • 5.7.1. Global Obesity Treatment Market, by Endoscopic Procedures, by Region, 2018 - 2030 (USD Billion)

6. Global Obesity Treatment Market, by Drug Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
• 6.3. Appetite suppressants
  • 6.3.1. Global Obesity Treatment Market, by Appetite suppressants, by Region, 2018 - 2030 (USD Billion)
• 6.4. Combination drugs
  • 6.4.1. Global Obesity Treatment Market, by Combination drugs, by Region, 2018 - 2030 (USD Billion)
• 6.5. Malabsorption
  • 6.5.1. Global Obesity Treatment Market, by Malabsorption, by Region, 2018 - 2030 (USD Billion)
• 6.6. Satiety drugs
  • 6.6.1. Global Obesity Treatment Market, by Satiety drugs, by Region, 2018 - 2030 (USD Billion)

7. Global Obesity Treatment Market, by End-Use

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
• 7.3. Clinics
  • 7.3.1. Global Obesity Treatment Market, by Clinics, by Region, 2018 - 2030 (USD Billion)
• 7.4. Hospitals
  • 7.4.1. Global Obesity Treatment Market, by Hospitals, by Region, 2018 - 2030 (USD Billion)
• 7.5. Beauty institutions
  • 7.5.1. Global Obesity Treatment Market, by Beauty institutions, by Region, 2018 - 2030 (USD Billion)
• 7.6. Others
  • 7.6.1. Global Other Obesity Treatment Market, by Region, 2018 - 2030 (USD Billion)

8. Global Obesity Treatment Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Obesity Treatment Market Assessment, By Geography, 2018 - 2030 (USD Billion)
• 8.3. Obesity Treatment Market - North America
  • 8.3.1. North America: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
  • 8.3.2. North America: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.3.3. North America: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.3.4. Obesity Treatment Market - U.S.
    • 8.3.4.1. U.S.: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.3.4.2. U.S.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.4.3. U.S.: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.3.5. Obesity Treatment Market - Canada
    • 8.3.5.1. Canada: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.3.5.2. Canada.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.3.5.3. Canada: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
• 8.4. Obesity Treatment Market - Europe
  • 8.4.1. Europe: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
  • 8.4.2. Europe.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.4.3. Europe: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.4. Obesity Treatment Market - UK
    • 8.4.4.1. UK: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.4.2. UK.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.4.3. UK: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.5. Obesity Treatment Market - France
    • 8.4.5.1. France: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.5.2. France.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.5.3. France: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.6. Obesity Treatment Market - Germany
    • 8.4.6.1. Germany: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.6.2. Germany.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.6.3. Germany: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.7. Obesity Treatment Market - Italy
    • 8.4.7.1. Italy: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.7.2. Italy.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.7.3. Italy: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.8. Obesity Treatment Market - Spain
    • 8.4.8.1. Spain: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.8.2. Spain.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.8.3. Spain: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.9. Obesity Treatment Market - Netherlands
    • 8.4.9.1. Netherlands: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.9.2. Netherlands.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.9.3. Netherlands: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.4.10. Obesity Treatment Market - Russia
    • 8.4.10.1. Russia: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.4.10.2. Russia.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.4.10.3. Russia: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
• 8.5. Obesity Treatment Market - Asia Pacific
  • 8.5.1. Asia Pacific: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
  • 8.5.2. Asia Pacific.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.5.3. Asia Pacific: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.4. Obesity Treatment Market - China
    • 8.5.4.1. China: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.4.2. China.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.4.3. China: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.5. Obesity Treatment Market - India
    • 8.5.5.1. India: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.5.2. India.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.5.3. India: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.6. Obesity Treatment Market - Malaysia
    • 8.5.6.1. Malaysia: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.6.2. Malaysia.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.6.3. Malaysia: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.7. Obesity Treatment Market - Japan
    • 8.5.7.1. Japan: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.7.2. Japan.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.7.3. Japan: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.8. Obesity Treatment Market - Indonesia
    • 8.5.8.1. Indonesia: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.8.2. Indonesia.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.8.3. Indonesia: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.5.9. Obesity Treatment Market - South Korea
    • 8.5.9.1. South Korea: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.5.9.2. South Korea.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.5.9.3. South Korea: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
• 8.6. Obesity Treatment Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
  • 8.6.2. Middle East & Africa.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.6.3. Middle East & Africa: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.6.4. Obesity Treatment Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.6.5. Obesity Treatment Market - UAE
    • 8.6.5.1. UAE: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.6.5.2. UAE.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.5.3. UAE: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.6.6. Obesity Treatment Market - Israel
    • 8.6.6.1. Israel: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.6.6.2. Israel.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.6.3. Israel: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.6.7. Obesity Treatment Market - South Africa
    • 8.6.7.1. South Africa: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.6.7.2. South Africa.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.6.7.3. South Africa: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
• 8.7. Obesity Treatment Market - Latin America
  • 8.7.1. Latin America: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
  • 8.7.2. Latin America.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
  • 8.7.3. Latin America: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.7.4. Obesity Treatment Market - Mexico
    • 8.7.4.1. Mexico: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.7.4.2. Mexico.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.4.3. Mexico: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.7.5. Obesity Treatment Market - Brazil
    • 8.7.5.1. Brazil: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.7.5.2. Brazil.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.5.3. Brazil: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)
  • 8.7.6. Obesity Treatment Market - Argentina
    • 8.7.6.1. Argentina: Obesity Treatment Market, by Surgery Type, 2018 - 2030 (USD Billion)
    • 8.7.6.2. Argentina.: Obesity Treatment Market, by End-Use, 2018 - 2030 (USD Billion)
    • 8.7.6.3. Argentina: Obesity Treatment Market, by Drug Type, 2018 - 2030 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. AbbVie Incorporation
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Apollo Endosurgery, Inc
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Arena Pharmaceuticals, Incorporation
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Atkins Nutritionals, Ltd
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. Brunswick Corporation
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. C.H. Boehringer Sohn AG & Ko. KG
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. EnteroMedics, Incorporation
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. F. Hoffmann-La Roche, Ltd
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Herbalife Ltd
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. Johnson & Johnson Services, Inc
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. Medtronic PLC
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Novo Nordisk A/S
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. NutriSystem, Incorporation
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Olympus Corporation
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. Orexigen Therapeutics, Inc
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development
• 10.16. Pfizer Incorporation
  • 10.16.1. Company Overview
  • 10.16.2. Financial Performance
  • 10.16.3. Product Benchmarking
  • 10.16.4. Recent Development
• 10.17. Technogym SpA
  • 10.17.1. Company Overview
  • 10.17.2. Financial Performance
  • 10.17.3. Product Benchmarking
  • 10.17.4. Recent Development
• 10.18. USGI Medical, Inc
  • 10.18.1. Company Overview
  • 10.18.2. Financial Performance
  • 10.18.3. Product Benchmarking
  • 10.18.4. Recent Development
• 10.19. Vivus, Inc.
  • 10.19.1. Company Overview
  • 10.19.2. Financial Performance
  • 10.19.3. Product Benchmarking
  • 10.19.4. Recent Development